The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

ImmunoGen Inc

Nasdaq: IMGN
Last

(U.S.) $5.86

Today's change-0.31 -5.02%
Updated October 20 4:00 PM EDT. Delayed by at least 15 minutes.
 

ImmunoGen Inc

Nasdaq: IMGN
Last

(U.S.) $5.86

Today's change-0.31 -5.02%
Updated October 20 4:00 PM EDT. Delayed by at least 15 minutes.

ImmunoGen Inc crosses below 125-day moving average

ImmunoGen Inc closed sharply lower Friday, dropping (U.S.)$0.31 or 5.02% to (U.S.)$5.86 and crossing below its 125-day moving average. Shares have lost 1.84% over the last five days, but have gained 187.25% over the last year to date. This security has outperformed the S&P 500 by 137.89% during the last year.

Key company metrics

  • Open(U.S.) $6.19
  • Previous close(U.S.) $6.17
  • High(U.S.) $6.21
  • Low(U.S.) $5.84
  • Bid / Ask(U.S.) $5.67 / (U.S.) $6.57
  • YTD % change+187.25%
  • Volume3,262,442
  • Average volume (10-day)4,414,413
  • Average volume (1-month)3,824,860
  • Average volume (3-month)3,667,638
  • 52-week range(U.S.) $1.51 to (U.S.) $8.84
  • Beta2.15
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$1.21
Updated October 20 4:00 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue3928148
Total other revenue--------
Total revenue3928148
Gross profit--------
Total cost of revenue--------
Total operating expense44414246
Selling / general / administrative9899
Research & development35333433
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)0004
Other operating expenses, total--------
Operating income-5-13-29-39
Interest income (expense), net non-operating-1-1-1-1
Gain (loss) on sale of assets--------
Other--------
Income before tax-9-17-34-45
Income after tax-9-17-34-45
Income tax, total--------
Net income-9-17-34-45
Total adjustments to net income------0
Net income before extra. items-9-17-34-45
Minority interest------0
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-9-17-34-45
Inc. avail. to common incl. extra. items-9-17-34-45
Diluted net income-9-17-34-45
Dilution adjustment--------
Diluted weighted average shares87878787
Diluted EPS excluding extraordinary itemsvalue per share-0.10-0.20-0.39-0.51
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.10-0.19-0.39-0.47